Synapse - Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers

Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers Journal Article

Authors:	Choudhury, N. J.; Marra, A.; Sui, J. S. Y.; Flynn, J.; Yang, S. R.; Falcon, C. J.; Selenica, P.; Schoenfeld, A. J.; Rekhtman, N.; Gomez, D.; Berger, M. F.; Ladanyi, M.; Arcila, M.; Rudin, C. M.; Riely, G. J.; Kris, M. G.; Heller, G.; Reis-Filho, J. S.; Yu, H. A.
Article Title:	Molecular biomarkers of disease outcomes and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
Journal Title:	Journal of Thoracic Oncology
Volume:	18
Issue:	4
ISSN:	1556-0864
Publisher:	Elsevier Inc.
Date Published:	2023-04-01
Start Page:	463
End Page:	475
Language:	English
DOI:	10.1016/j.jtho.2022.11.022
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
PUBMED:	36494075
PMCID:	PMC10249779
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=162705000&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Helena Yu -- Accession Number: 162705000 -- Entry Date: In Process -- Revision Date: 20230329 -- Publication Type: Article -- Journal Subset: Biomedical; Blind Peer Reviewed; Peer Reviewed; USA -- NLM UID: 101274235. -- Source: Cinahl